Article

Iinvezz.com on 2023-05-24 16:32

Eli Lilly stock price forecast ahead of obesity drug approval

Bank of America analyst Geoff Meacham raises its price target on Eli Lilly to $500. Find out why he's bullish.

North America

Related news

Eli Lilly & Co: Eli Lilly to seek obesity drug approval that could disrupt weight loss market Financial Times
Pharmaceuticals sector: Approval for Eli Lilly obesity drug sets up rival to Wegovy Financial Times
IEli Lilly stock spiked after Biogen’s Aduhelm approval: here is why invezz.com
Phase 2
Obesity drug shows promise, Eli Lilly says Arkansas Online
DAnalyst revamps Eli Lilly stock price target on weight loss drug dcourier.com
Wall Street
Eli Lilly ends drug development, stock plunges USA today
Wall Street , Indianapolis
FEli Lilly & Co: Eli Lilly predicts sales jump from obesity drug demand ft.com
IGina Sanchez makes a bull case for Eli Lilly & Co invezz.com
The Exchange , North America
BEli Lilly Boosts 2021 Guidance and Issues a Strong 2022 Forecast. The Stock Jumps.1 min read barrons.com
Eli Lilly & Co: Eli Lilly to seek US approval after Alzheimer’s drug trial success Financial Times
Eli Lilly applies for FDA approval on Alzheimer’s drug nwaonline.com
Rochester , San Francisco , New York , Amsterdam , Indianapolis
Eli Lilly michronicleonline.com
Puerto Rico
IPoint Biopharma stock nearly doubles on Eli Lilly deal invezz.com
IEli Lilly Q2 results: its Alzheimer’s drug could be ‘the biggest drug in history’invezz.com
Wall Street , China , North America
Is Pfizer Stock A Better Bet Compared To Eli Lilly?Forbes
Americas
BEli Lilly Stock Is Up as Earnings Edge Past Expectations barrons.com
Stock Island
Drugmaker Eli Lilly tops 2Q expectations, raises forecast journalrecord.com
Is There A Better Pick Over Eli Lilly Stock?Forbes
Ireland , United Kingdom , Stock Island , France , Paris